Live Breaking News & Updates on Consonance Capital Management

Stay updated with breaking news from Consonance capital management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Arix Bioscience plc Announces Changes to Board of Directors

Investegate announcements from Arix Bioscience PLC, Arix Bioscience plc Announces Changes to Board of Directors ....

United Kingdom , City Of , Ibrahim Khalil , Andrew Smith , Sarah Macleod , Arix Bioscience , Benny Soffer , Nick Johnson , Smithkline Beecham , Michael Bunbury , Debra Barker , Yale University , Santhera Pharmaceuticals , Emory University , Queen College , Institute Of Management Accountants , Powerscourt Group , Durham University Business School , King College , Company Audit Committee , Company Remuneration Committee , Liverpool John Moores University , Sucampo Pharmaceuticals Inc , Announces Changes , Senior Independent Director , Sir Michael Bunbury ,

Arix Bioscience plc Announces Changes to Board of Directors

DJ Arix Bioscience plc Announces Changes to Board of Directors Arix Bioscience PLC (ARIX) Arix Bioscience plc Announces Changes to Board of Directors 10-Aug-2022 / 07:01 GMT/BST Dissemination of ....

United Kingdom , City Of , Ibrahim Khalil , Andrew Smith , Sarah Macleod , Arix Bioscience , Benny Soffer , Nick Johnson , Smithkline Beecham , Michael Bunbury , Debra Barker , Yale University , Santhera Pharmaceuticals , Emory University , Queen College , Institute Of Management Accountants , Powerscourt Group , Durham University Business School , King College , News Service , Company Audit Committee , Company Remuneration Committee , Liverpool John Moores University , Sucampo Pharmaceuticals Inc , Announces Changes , Regulatory Announcement ,

Surrozen, Inc. (NASDAQ:SRZN) Expected to Post Earnings of -$0.49 Per Share

Brokerages forecast that Surrozen, Inc. (NASDAQ:SRZN – Get Rating) will report earnings per share of ($0.49) for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Surrozen’s earnings. The business is scheduled to announce its next earnings results on Monday, January 1st. On average, analysts expect that Surrozen will report full year […] ....

Penserra Capital Management , Zacks Investment Research , Surrozen Inc , Surrozen Company Profile Get Rating , Millennium Management , Get Rating , Montreal Can , Capital Management , Consonance Capital Management , Company Profile , Nasdaq Srzn ,

Zacks: Brokerages Expect Silence Therapeutics plc (NASDAQ:SLN) to Announce -$0.62 EPS

Equities research analysts forecast that Silence Therapeutics plc (NASDAQ:SLN – Get Rating) will report ($0.62) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Silence Therapeutics’ earnings. The firm is scheduled to report its next quarterly earnings results on Monday, January 1st. On average, analysts expect that Silence […] ....

Lombard Odier Asset Management United States Corp , Goldman Sachs Group Inc , Zacks Investment Research , Silence Therapeutics Company Profile Get Rating , Frazier Management , Silence Therapeutics , Get Rating , Silence Therapeutic , Odier Asset Management United States Corp , Track Capital , Sachs Group , Consonance Capital Management , Capital Management , Therapeutics Company Profile , Oligonucleotide Discovery , Nasdaq Sln ,

8 Medical Stocks to Buy According to Mitchell Blutt's Consonance Capital

In this article, we will be looking at the 8 medical stocks to buy according to Mitchell Blutt s Consonance Capital. ....

United States , Mitchell Blutt , Tazeen Ahmad , Globus Medical Inc , University Of Pennsylvania School Medicine , Tandem Diabetes Care Inc , United Therapeutics Corporation , Number Of Hedge Fund Holders , Springworks Therapeutics Inc , Olink Holding , Surrozen Inc , University Of Pennsylvania , Pharmaceuticals Inc , Baron Discovery Fund , Buy According , Pennsylvania School , Consonance Capital , Consonance Capital Management , Tandem Diabetes Care , Globus Medical , Hedge Fund Holders , Capital Management , Discovery Fund , Silence Therapeutics , Insider Monkey , Works Therapeutics ,